ConvaTec Group (LON:CTEC) Insider Jonny Mason Buys 50,000 Shares

ConvaTec Group PLC (LON:CTECGet Free Report) insider Jonny Mason acquired 50,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was purchased at an average price of GBX 201 per share, for a total transaction of £100,500.

Jonny Mason also recently made the following trade(s):

  • On Monday, March 16th, Jonny Mason sold 291,149 shares of ConvaTec Group stock. The shares were sold at an average price of GBX 234, for a total value of £681,288.66.

ConvaTec Group Trading Up 1.9%

Shares of ConvaTec Group stock opened at GBX 204.98 on Wednesday. ConvaTec Group PLC has a 52-week low of GBX 195.90 and a 52-week high of GBX 311.20. The stock’s 50-day simple moving average is GBX 219.11 and its 200 day simple moving average is GBX 229.95. The stock has a market capitalization of £4.01 billion, a P/E ratio of 23.83, a P/E/G ratio of 0.93 and a beta of 0.78. The company has a debt-to-equity ratio of 106.19, a quick ratio of 0.96 and a current ratio of 1.53.

Wall Street Analyst Weigh In

CTEC has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a report on Wednesday, April 8th. Citigroup cut their price objective on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a report on Monday, May 18th. Berenberg Bank reissued a “buy” rating and set a GBX 340 price objective on shares of ConvaTec Group in a report on Tuesday, April 21st. Stifel Nicolaus reissued a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a report on Wednesday, March 11th. Finally, Jefferies Financial Group reissued a “buy” rating and set a GBX 325 price objective on shares of ConvaTec Group in a report on Friday, May 15th. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, ConvaTec Group has an average rating of “Moderate Buy” and a consensus target price of GBX 308.78.

Read Our Latest Stock Analysis on ConvaTec Group

ConvaTec Group Company Profile

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

See Also

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.